Cancer Care

Your daily prebiotic fix won’t just keep you feeling full, improve your digestion and help you fight the latest bug going around your office, it may also just decrease your risk of getting colon cancer. Specifically, early stage cancer cells were found to be sensitive to inulin. German researchers reported in the British Journal of Nutrition that human colon cells in the early and late stages of cancer exposed to inulin in vitro were more likely to die. These findings open the way to implications for possible prevention. (Munjal U. et al. British Journal of Nutrition. September 2009, 102(5): 663-671.)

Inulin is a prebiotic, a compound found in many of the foods we eat that promotes the growth of beneficial gut bacteria by providing a medium, or “food” to help them flourish.
(more…)

Colonoscopies performed in the early morning detect more polyps than colon cancer testing done later in the day, according to new research.

A study that appears in the November issue of Clinical Gastroenterology and Hepatology found that the number of colon polyps found during testing decreases by the hour throughout the day, HealthDay News reports.
(more…)

According to the Indian Council of Medical Research’s (ICMR) projection in a landmark Trends in Cancer report, yet to be made public, the country will see a 21 per cent overall increase - over 1.06 lakh additional cases of cancer every year in women by 2020, as against 79,000 new cases of cancer in men during the same period.

This landmark analysis, based on the pattern of cancer incidence between 1982-2005 (24 years) in India, has made some startling revelations. Cases of leukaemia or blood cancer will increase by almost 77 per cent in women by 2020, followed by cancer of the colon (69 per cent) and liver (61 per cent). However, in sheer numbers, the main culprit in the next 10 years will be breast cancer.
(more…)

CHICAGO — Where does ImClone Systems(IMCL - Cramer’s Take - Stockpickr) stock price go from here?

That’s the most pressing question on many biotech investors’ minds as Monday trading looms after a very busy weekend of new Erbitux clinical data at the American Society of Clinical Oncology (ASCO) annual meeting.
(more…)